MedWatch

Flemming Ørnskov steps down as CEO in Shire - the future is uncertain

CEO in Shire, Flemming Ørnskov, steps down after Takeda completed its acquisition of the company. He will continue as advisor for Takeda for three months, but what comes next is unknown.

Foto: Linda Kastrup/Scanpix

After six years as head of Irish drug group Shire, Danish Flemming Ørnskov has handed in his resignation.

This is according to a note from Takeda issued in connection with the company's completion of the acquisition of Shire for approximately DKK 400 billion (USD 61.31 billion).

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier